ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

June 4, 2004

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

May 1, 2009

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

May 2, 2008

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

Ethics Commission Say HHS Should Test Injury Compensation

June 18, 1982

Abstracts From AACR Annual Meeting

May 28, 1976